Damian Marron

Dr. Damian Marron is a Chairman at Nicox SA, a Chairman at Circio Holding ASA, a Chairman at Indegra Therapeutics Ltd., a Chairman at Onya Therapeutics Ltd., a Head-Biopharma at Treehill Partners, LLC and a Non-Executive Chairman at Hone Bio Ltd. He is on the Board of Directors at Cantargia AB, Resolys Bio, Inc., Agalimmune Ltd. and Loxbridge Research LLP.
Dr. Marron was previously employed as an Independent Non-Executive Director by Bone Therapeutics SA, a Chief Executive Officer & Director by TxCell SA, a Chief Executive Officer by Trophos SA, a Head-European Business Development by Bausch & Lomb (Australia) Pty Ltd., a Director-Clinical Operations by Rhone-Poulenc Rorer BV, a Clinical Research Associate by Glaxo Wellcome Immobilière de Recherche SA, a Non-Executive Chairman by Cytheris SA, a Non-Executive Chairman by Imophoron Ltd., a Manager-Drug Group by Orphan Europe SARL, and a Chairman by PepGen Ltd. He also served on the board at France Biotech Association and Theralpha.
He received his undergraduate degree from The University of Liverpool.